The biggest shot in the arm for new OTC deliveries which may be happening now will turn into cash in the December quarterly. OTC sales ebbs and flows depend on mega batch delivery dates with the cash follow-on 90 days later. Quarterly cash for OTC will always be a quarter behind actual sales.
Clearly a convergence of OTC news, diagnostic milestone news (and cash) and therapeutic news is expected this quarter and next. I would very much have liked to see have seen new diagnostic milestone payments happen in time for the June quarterly but 3rd party progress happens when it happens. Guidance remains very positive on ALL of many fronts IMHO.
cheers
The biggest shot in the arm for new OTC deliveries which may be...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AN1 (ASX) Chart |
Day chart unavailable